Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin
- 1 August 2003
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 169 (2) , 283-291
- https://doi.org/10.1016/s0021-9150(03)00193-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbitsAtherosclerosis, 1993
- The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosisThe Journal of Pathology, 1993
- Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.Journal of Clinical Investigation, 1993
- Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patientsThe Lancet, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemiaThe Lancet, 1992
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991